Show simple item record

dc.contributor.authorHenman, Martinen
dc.contributor.authorCadogan, Cathalen
dc.date.accessioned2020-12-02T17:48:56Z
dc.date.available2020-12-02T17:48:56Z
dc.date.issued2020en
dc.date.submitted2020en
dc.identifier.citationPaudyal V, Cadogan C, Fialová D, Henman MC, Hazen A, Okuyan B, Lutters M, Stewart D, Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries, Research in Social & Administrative Pharmacy, 17, 8, 2020, 1507 - 1517en
dc.identifier.issn1551-7411en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/94305
dc.descriptionPUBLISHEDen
dc.descriptionAvailable online 30 November 2020; https://www.sciencedirect.com/science/article/pii/S155174112031202X?via%3Dihuben
dc.description.abstractBackground: The pharmacy profession has an important role in the frontline healthcare response to COVID-19 across all settings. Objective: This study sought to explore the views and experiences of clinical pharmacists in relation to the provision of clinical pharmacy services during COVID-19. Methods: Semi-structured qualitative interviews were conducted with pharmacists working in clinical roles in healthcare settings across Europe. Participants were recruited through professional organisations of clinical and hospitals pharmacists combined with a snowballing technique. The Pharmacy Emergency Preparedness and Response Framework and Disaster Preparedness Framework for pharmacy services were used to generate data which were analysed using the thematic framework method. Results: Twenty-two participants from 16 European countries described a range of measures to protect patients, public and healthcare staff against virus transmission including developing and disseminating educational materials. Most described their involvement in aspects of evidence provision such as facilitating clinical trials, gathering and appraising evidence and disseminating clinical information. Many hospital-based pharmacists were reassigned to new roles such as intensive care. Routine clinical services were extensively interrupted and remote forms of communication were used. Most were motivated by a strong sense of professionalism to continue delivering services. A number of facilitators and barriers to prevention, preparedness and response actions were identified which related to uptake of new roles, recognition of pharmacists roles in the healthcare team, information gathering, communication with patients and healthcare professionals, and provision of routine clinical services. Conclusions: Participants in this multinational qualitative study described a range of service adaptations and adoption of novel roles to prevent and mitigate the public health impact of the pandemic. The study findings may help to inform governments, public health agencies and healthcare systems in harnessing ongoing service provision and adapt to any future interruptions.en
dc.format.extent1507en
dc.format.extent1517en
dc.language.isoenen
dc.relation.ispartofseriesResearch in Social & Administrative Pharmacyen
dc.relation.ispartofseries17en
dc.relation.ispartofseries8en
dc.rightsYen
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.subjectPandemicen
dc.subjectPharmacisten
dc.subjectClinical Pharmacyen
dc.subjectPharmaceutical careen
dc.titleProvision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countriesen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/mhenmanen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/cadogacaen
dc.identifier.rssinternalid222079en
dc.identifier.doihttps://doi.org/10.1016/j.sapharm.2020.11.017en
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeInclusive Societyen
dc.identifier.rssotherhttps://www.sciencedirect.com/science/article/pii/S155174112031202X?via%3Dihuben
dc.subject.TCDTagBehavior and Healthen
dc.subject.TCDTagCOVID 19en
dc.subject.TCDTagClinical Pharmacyen
dc.subject.TCDTagCommunity Healthen
dc.subject.TCDTagEUROPEen
dc.subject.TCDTagEUROPEANen
dc.subject.TCDTagEUROPEAN COUNTRIESen
dc.subject.TCDTagHEALTHen
dc.subject.TCDTagHEALTH BEHAVIORen
dc.subject.TCDTagHEALTH CAREen
dc.subject.TCDTagHEALTH CARE ORGANIZATIONen
dc.subject.TCDTagHEALTH CARE UTILIZATIONen
dc.subject.TCDTagHEALTH PROFESSIONALSen
dc.subject.TCDTagHEALTH SERVICES RESEARCHen
dc.subject.TCDTagHEALTH-CAREen
dc.subject.TCDTagHEALTH-CARE PROVIDERSen
dc.subject.TCDTagHEALTH-CARE UTILIZATIONen
dc.subject.TCDTagHEALTHCARE USEen
dc.subject.TCDTagHealth Careen
dc.subject.TCDTagHealth Communicationen
dc.subject.TCDTagHealth Service Utilisationen
dc.subject.TCDTagHealth Services Deliveryen
dc.subject.TCDTagHealthcareen
dc.subject.TCDTagHealthcare Utilisationen
dc.subject.TCDTagPHARMACEUTICAL CAREen
dc.subject.TCDTagPandemicen
dc.subject.TCDTagPatient safetyen
dc.subject.TCDTagPharmacists role in health education and promotionen
dc.subject.TCDTagPharmacyen
dc.subject.TCDTagPharmacy practiceen
dc.subject.TCDTagPractice of pharmacyen
dc.subject.TCDTagPublic Healthen
dc.subject.TCDTagUse of health servicesen
dc.subject.TCDTagcommunity pharmacyen
dc.subject.TCDTaghealth care and health servicesen
dc.subject.TCDTaghealth service provisionen
dc.subject.TCDTaghealth services researchen
dc.subject.TCDTaghealthcare servicesen
dc.subject.TCDTagpharmacy servicesen
dc.subject.TCDTagpopulation healthen
dc.identifier.orcid_id0000-0002-7922-7691en
dc.status.accessibleNen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record